Dutasteride reduces the risk of biopsy-detectable prostate cancer and BPH complications among men at increased prostate cancer risk with concomitant BPH: sub-analysis from the REDUCE study

    Activity: Talk or presentationConference presentation

    Description

    Contributors: Marberger M, Montorsi F, Tammela T, Andriole G, Wilson T, Fueyo-Rodriguez A, Castro R on behalf of the REDUCE study group
    Period11 Oct 2009
    Event titleThe 6th World Congress on Men’s Health 2009
    Event typeOther
    Degree of RecognitionInternational